Skip to content
Screener

Opko Health OPK Diagnostics — Operating Income

Other segment segments

Pharmaceutical
$839K+103%

Similar metrics at other companies

Labcorp Holdings logo
LHDiagnostics — Operating Income
$458.7M+7.3%
WAT
WATWaters Advanced Diagnostics — Operating Income
$70M+250%
TEC
TECHDiagnostics And Spatial Biology — Operating Income
$10.32M+22.5%
DWS
DWSNCanada Operations — Operating Income
$5.4M-2.8%
Southern Copper logo
SCCOPeruvian Operations — Operating Income
$923.7M+64.5%
Falcon's Beyond Global logo
FBYDDestination Operations — Operating Income
-$242K+36.3%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
(In thousands) / Revenue from services: / PharmaceuticalFor the three months ended June 30, 2026 / —For the three months ended June 30, 2025 / —For the six months ended June 30, 2026 / —For the six months ended June 30, 2025 / —
Diagnostics(18,070)(18,070)
Corporate
$(18,070)$—$(18,070)$—
Segment operating loss:
Pharmaceutical$839$(28,706)$(28,839)$(63,470)
Diagnostics4,756(18,164)(8,196)(42,082)
Corporate(12,567)(13,111)(20,952)(21,596)
$(6,972)$(59,981)$(57,987)$(127,148)

Item 1. Financial Statements

FAQ

What is Opko Health's diagnostics — operating income?
Opko Health (OPK) reported diagnostics — operating income of $4.76M in Q2 2026.
How has Opko Health's diagnostics — operating income changed year-over-year?
Opko Health's diagnostics — operating income increased by 126.2% year-over-year, from -$18.16M to $4.76M.
What is the long-term trend for Opko Health's diagnostics — operating income?
Over 2 years (2022 to 2024), Opko Health's diagnostics — operating income has grown at a -62.7% compound annual growth rate (CAGR), from -$173.66M to -$24.13M.
What does diagnostics — operating income mean?
Measures the profit or loss generated by the diagnostics segment after deducting all operating expenses, including cost of goods sold, SG&A, and R&D. This is the primary metric for assessing the core operational health and profitability of the diagnostics business unit. It excludes interest, taxes, and non-operating items to focus strictly on segment performance.

Ask your AI about Opko Health's diagnostics — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude